10,179
Participants
Start Date
June 30, 2010
Primary Completion Date
November 30, 2014
Study Completion Date
December 31, 2014
Patients with Atrial Fibrillation (AF)
Treatment patterns of AF according to patient demographics, clinical factors, risk stratification, and geographic regions.
Birmingham
Dothan
Huntsville
Mobile
Montgomery
Pell City
Tuscaloosa
Cottonwood
Tucson
Fort Smith
Carlsbad
Carmichael
Corona
Laguna Hills
Long Beach
Los Alamitos
Los Angeles
Montebello
Northridge
Orange
Oxnard
Palo Alto
Pismo Beach
Pomona
San Diego
San Ramon
Santa Rosa
Tarzana
Torrance
Tustin
Ventura
Aurora
Colorado Springs
Golden
Newark
Seaford
Boynton Beach
Coral Springs
Deerfield Beach
Fort Myers
Fort Walton Beach
Hollywood
Jupiter
Lakeland
Oakland Park
Orange Park
Ormond Beach
Port Charlotte
St. Petersburg
Tallahassee
Atlanta
Decatur
Marietta
Riverdale
Idaho Falls
Nampa
Aurora
Evergreen Park
Melrose Park
Peoria
Rock Island
Rockford
Urbana
Winfield
Bloomington
Evansville
Hammond
Indianapolis
La Porte
South Bend
Waterloo
Overland Park
Crestview Hills
Lexington
Owensboro
Alexandria
Rockport
Beltsville
Salisbury
Biddeford
Bay City
Bridgman
Commerce
Grand Blanc
Lansing
Livonia
Mount Clemens
Stevensville
Traverse City
Troy
Minneapolis
Anaconda
Omaha
Las Vegas
Bridgewater
Elmer
Haddon Heights
Linden
Nampa
Ridgewood
Sewell
Toms River
Flushing
Huntington
Jamaica
New York
Northport
Calabash
Charlotte
Durham
Greenwood
Jacksonville
Pinehurst
Raleigh
Sanford
Tabor City
Winston-Salem
Fargo
Minot
Mansfield
Miamisburg
Piqua
Toledo
Worthington
Youngstown
Abington
Beaver
Danville
Doylestown
Erie
Lansdale
Philadelphia
Scranton
Spring House
West Reading
Wynnewood
Yardley
Pawtucket
Anderson
Easley
Spartanburg
Harriman
Kingsport
Nashville
Arlington
Beaumont
Corpus Christi
Flower Mound
Fort Worth
Houston
McAllen
Odessa
Plano
San Antonio
Tomball
Salt Lake City
Fredericksburg
Lynchburg
Midlothian
Roanoke
Winchester
Burien
Port Orchard
Spokane
Tacoma
Vancouver
La Crosse
Madison
Hato Rey
Río Grande
San Juan
Collaborators (2)
Duke Clinical Research Institute
OTHER
Bayer
INDUSTRY
Janssen Scientific Affairs, LLC
INDUSTRY